Global Sexually Transmitted Disease Therapeutics Market Growth (Status and Outlook) 2025-2031

September 2025 | 88 pages | ID: GBA5EA1A9C7EN
LP Information

Abstracts

According to this study, the global Sexually Transmitted Disease Therapeutics market size will reach US$ million by 2031.

Sexually transmitted diseases are infections that are passed from one person to another through sexual contact.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Sexually Transmitted Disease Therapeutics Industry Forecast” looks at past sales and reviews total world Sexually Transmitted Disease Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Sexually Transmitted Disease Therapeutics sales for 2025 through 2031. With Sexually Transmitted Disease Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sexually Transmitted Disease Therapeutics industry.

This Insight Report provides a comprehensive analysis of the global Sexually Transmitted Disease Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Sexually Transmitted Disease Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sexually Transmitted Disease Therapeutics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sexually Transmitted Disease Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sexually Transmitted Disease Therapeutics.

This report presents a comprehensive overview, market shares, and growth opportunities of Sexually Transmitted Disease Therapeutics market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Gonorrhea
• Syphilis
• Chlamydia
• Trichomoniasis

Segmentation by Application:

• Hospitals
• Diagnostic Laboratories
• Research and Academic Laboratories
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Abbott
• Roche
• BD
• BioM?rieux
• Bio-Rad
• Cepheid

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Sexually Transmitted Disease Therapeutics Market Size (2020-2031)
  2.1.2 Sexually Transmitted Disease Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Sexually Transmitted Disease Therapeutics by Country/Region (2020, 2024 & 2031)
2.2 Sexually Transmitted Disease Therapeutics Segment by Type
  2.2.1 Gonorrhea
  2.2.2 Syphilis
  2.2.3 Chlamydia
  2.2.4 Trichomoniasis
2.3 Sexually Transmitted Disease Therapeutics Market Size by Type
  2.3.1 Sexually Transmitted Disease Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Sexually Transmitted Disease Therapeutics Market Size Market Share by Type (2020-2025)
2.4 Sexually Transmitted Disease Therapeutics Segment by Application
  2.4.1 Hospitals
  2.4.2 Diagnostic Laboratories
  2.4.3 Research and Academic Laboratories
  2.4.4 Others
2.5 Sexually Transmitted Disease Therapeutics Market Size by Application
  2.5.1 Sexually Transmitted Disease Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Sexually Transmitted Disease Therapeutics Market Size Market Share by Application (2020-2025)

3 SEXUALLY TRANSMITTED DISEASE THERAPEUTICS MARKET SIZE BY PLAYER

3.1 Sexually Transmitted Disease Therapeutics Market Size Market Share by Player
  3.1.1 Global Sexually Transmitted Disease Therapeutics Revenue by Player (2020-2025)
  3.1.2 Global Sexually Transmitted Disease Therapeutics Revenue Market Share by Player (2020-2025)
3.2 Global Sexually Transmitted Disease Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 SEXUALLY TRANSMITTED DISEASE THERAPEUTICS BY REGION

4.1 Sexually Transmitted Disease Therapeutics Market Size by Region (2020-2025)
4.2 Global Sexually Transmitted Disease Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Sexually Transmitted Disease Therapeutics Market Size Growth (2020-2025)
4.4 APAC Sexually Transmitted Disease Therapeutics Market Size Growth (2020-2025)
4.5 Europe Sexually Transmitted Disease Therapeutics Market Size Growth (2020-2025)
4.6 Middle East & Africa Sexually Transmitted Disease Therapeutics Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Sexually Transmitted Disease Therapeutics Market Size by Country (2020-2025)
5.2 Americas Sexually Transmitted Disease Therapeutics Market Size by Type (2020-2025)
5.3 Americas Sexually Transmitted Disease Therapeutics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Sexually Transmitted Disease Therapeutics Market Size by Region (2020-2025)
6.2 APAC Sexually Transmitted Disease Therapeutics Market Size by Type (2020-2025)
6.3 APAC Sexually Transmitted Disease Therapeutics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Sexually Transmitted Disease Therapeutics Market Size by Country (2020-2025)
7.2 Europe Sexually Transmitted Disease Therapeutics Market Size by Type (2020-2025)
7.3 Europe Sexually Transmitted Disease Therapeutics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Sexually Transmitted Disease Therapeutics by Region (2020-2025)
8.2 Middle East & Africa Sexually Transmitted Disease Therapeutics Market Size by Type (2020-2025)
8.3 Middle East & Africa Sexually Transmitted Disease Therapeutics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL SEXUALLY TRANSMITTED DISEASE THERAPEUTICS MARKET FORECAST

10.1 Global Sexually Transmitted Disease Therapeutics Forecast by Region (2026-2031)
  10.1.1 Global Sexually Transmitted Disease Therapeutics Forecast by Region (2026-2031)
  10.1.2 Americas Sexually Transmitted Disease Therapeutics Forecast
  10.1.3 APAC Sexually Transmitted Disease Therapeutics Forecast
  10.1.4 Europe Sexually Transmitted Disease Therapeutics Forecast
  10.1.5 Middle East & Africa Sexually Transmitted Disease Therapeutics Forecast
10.2 Americas Sexually Transmitted Disease Therapeutics Forecast by Country (2026-2031)
  10.2.1 United States Market Sexually Transmitted Disease Therapeutics Forecast
  10.2.2 Canada Market Sexually Transmitted Disease Therapeutics Forecast
  10.2.3 Mexico Market Sexually Transmitted Disease Therapeutics Forecast
  10.2.4 Brazil Market Sexually Transmitted Disease Therapeutics Forecast
10.3 APAC Sexually Transmitted Disease Therapeutics Forecast by Region (2026-2031)
  10.3.1 China Sexually Transmitted Disease Therapeutics Market Forecast
  10.3.2 Japan Market Sexually Transmitted Disease Therapeutics Forecast
  10.3.3 Korea Market Sexually Transmitted Disease Therapeutics Forecast
  10.3.4 Southeast Asia Market Sexually Transmitted Disease Therapeutics Forecast
  10.3.5 India Market Sexually Transmitted Disease Therapeutics Forecast
  10.3.6 Australia Market Sexually Transmitted Disease Therapeutics Forecast
10.4 Europe Sexually Transmitted Disease Therapeutics Forecast by Country (2026-2031)
  10.4.1 Germany Market Sexually Transmitted Disease Therapeutics Forecast
  10.4.2 France Market Sexually Transmitted Disease Therapeutics Forecast
  10.4.3 UK Market Sexually Transmitted Disease Therapeutics Forecast
  10.4.4 Italy Market Sexually Transmitted Disease Therapeutics Forecast
  10.4.5 Russia Market Sexually Transmitted Disease Therapeutics Forecast
10.5 Middle East & Africa Sexually Transmitted Disease Therapeutics Forecast by Region (2026-2031)
  10.5.1 Egypt Market Sexually Transmitted Disease Therapeutics Forecast
  10.5.2 South Africa Market Sexually Transmitted Disease Therapeutics Forecast
  10.5.3 Israel Market Sexually Transmitted Disease Therapeutics Forecast
  10.5.4 Turkey Market Sexually Transmitted Disease Therapeutics Forecast
10.6 Global Sexually Transmitted Disease Therapeutics Forecast by Type (2026-2031)
10.7 Global Sexually Transmitted Disease Therapeutics Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Sexually Transmitted Disease Therapeutics Forecast

11 KEY PLAYERS ANALYSIS

11.1 Abbott
  11.1.1 Abbott Company Information
  11.1.2 Abbott Sexually Transmitted Disease Therapeutics Product Offered
  11.1.3 Abbott Sexually Transmitted Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Abbott Main Business Overview
  11.1.5 Abbott Latest Developments
11.2 Roche
  11.2.1 Roche Company Information
  11.2.2 Roche Sexually Transmitted Disease Therapeutics Product Offered
  11.2.3 Roche Sexually Transmitted Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Roche Main Business Overview
  11.2.5 Roche Latest Developments
11.3 BD
  11.3.1 BD Company Information
  11.3.2 BD Sexually Transmitted Disease Therapeutics Product Offered
  11.3.3 BD Sexually Transmitted Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 BD Main Business Overview
  11.3.5 BD Latest Developments
11.4 BioM?rieux
  11.4.1 BioM?rieux Company Information
  11.4.2 BioM?rieux Sexually Transmitted Disease Therapeutics Product Offered
  11.4.3 BioM?rieux Sexually Transmitted Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 BioM?rieux Main Business Overview
  11.4.5 BioM?rieux Latest Developments
11.5 Bio-Rad
  11.5.1 Bio-Rad Company Information
  11.5.2 Bio-Rad Sexually Transmitted Disease Therapeutics Product Offered
  11.5.3 Bio-Rad Sexually Transmitted Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Bio-Rad Main Business Overview
  11.5.5 Bio-Rad Latest Developments
11.6 Cepheid
  11.6.1 Cepheid Company Information
  11.6.2 Cepheid Sexually Transmitted Disease Therapeutics Product Offered
  11.6.3 Cepheid Sexually Transmitted Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Cepheid Main Business Overview
  11.6.5 Cepheid Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Sexually Transmitted Disease Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Sexually Transmitted Disease Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Gonorrhea
Table 4. Major Players of Syphilis
Table 5. Major Players of Chlamydia
Table 6. Major Players of Trichomoniasis
Table 7. Sexually Transmitted Disease Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Sexually Transmitted Disease Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 9. Global Sexually Transmitted Disease Therapeutics Market Size Market Share by Type (2020-2025)
Table 10. Sexually Transmitted Disease Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Sexually Transmitted Disease Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Sexually Transmitted Disease Therapeutics Market Size Market Share by Application (2020-2025)
Table 13. Global Sexually Transmitted Disease Therapeutics Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Sexually Transmitted Disease Therapeutics Revenue Market Share by Player (2020-2025)
Table 15. Sexually Transmitted Disease Therapeutics Key Players Head office and Products Offered
Table 16. Sexually Transmitted Disease Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Sexually Transmitted Disease Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Sexually Transmitted Disease Therapeutics Market Size Market Share by Region (2020-2025)
Table 21. Global Sexually Transmitted Disease Therapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Sexually Transmitted Disease Therapeutics Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Sexually Transmitted Disease Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Sexually Transmitted Disease Therapeutics Market Size Market Share by Country (2020-2025)
Table 25. Americas Sexually Transmitted Disease Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 26. Americas Sexually Transmitted Disease Therapeutics Market Size Market Share by Type (2020-2025)
Table 27. Americas Sexually Transmitted Disease Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Sexually Transmitted Disease Therapeutics Market Size Market Share by Application (2020-2025)
Table 29. APAC Sexually Transmitted Disease Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Sexually Transmitted Disease Therapeutics Market Size Market Share by Region (2020-2025)
Table 31. APAC Sexually Transmitted Disease Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 32. APAC Sexually Transmitted Disease Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Sexually Transmitted Disease Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Sexually Transmitted Disease Therapeutics Market Size Market Share by Country (2020-2025)
Table 35. Europe Sexually Transmitted Disease Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 36. Europe Sexually Transmitted Disease Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Sexually Transmitted Disease Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Sexually Transmitted Disease Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 39. Middle East & Africa Sexually Transmitted Disease Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Sexually Transmitted Disease Therapeutics
Table 41. Key Market Challenges & Risks of Sexually Transmitted Disease Therapeutics
Table 42. Key Industry Trends of Sexually Transmitted Disease Therapeutics
Table 43. Global Sexually Transmitted Disease Therapeutics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 44. Global Sexually Transmitted Disease Therapeutics Market Size Market Share Forecast by Region (2026-2031)
Table 45. Global Sexually Transmitted Disease Therapeutics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 46. Global Sexually Transmitted Disease Therapeutics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 47. Abbott Details, Company Type, Sexually Transmitted Disease Therapeutics Area Served and Its Competitors
Table 48. Abbott Sexually Transmitted Disease Therapeutics Product Offered
Table 49. Abbott Sexually Transmitted Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. Abbott Main Business
Table 51. Abbott Latest Developments
Table 52. Roche Details, Company Type, Sexually Transmitted Disease Therapeutics Area Served and Its Competitors
Table 53. Roche Sexually Transmitted Disease Therapeutics Product Offered
Table 54. Roche Sexually Transmitted Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. Roche Main Business
Table 56. Roche Latest Developments
Table 57. BD Details, Company Type, Sexually Transmitted Disease Therapeutics Area Served and Its Competitors
Table 58. BD Sexually Transmitted Disease Therapeutics Product Offered
Table 59. BD Sexually Transmitted Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. BD Main Business
Table 61. BD Latest Developments
Table 62. BioM?rieux Details, Company Type, Sexually Transmitted Disease Therapeutics Area Served and Its Competitors
Table 63. BioM?rieux Sexually Transmitted Disease Therapeutics Product Offered
Table 64. BioM?rieux Sexually Transmitted Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. BioM?rieux Main Business
Table 66. BioM?rieux Latest Developments
Table 67. Bio-Rad Details, Company Type, Sexually Transmitted Disease Therapeutics Area Served and Its Competitors
Table 68. Bio-Rad Sexually Transmitted Disease Therapeutics Product Offered
Table 69. Bio-Rad Sexually Transmitted Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. Bio-Rad Main Business
Table 71. Bio-Rad Latest Developments
Table 72. Cepheid Details, Company Type, Sexually Transmitted Disease Therapeutics Area Served and Its Competitors
Table 73. Cepheid Sexually Transmitted Disease Therapeutics Product Offered
Table 74. Cepheid Sexually Transmitted Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. Cepheid Main Business
Table 76. Cepheid Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Sexually Transmitted Disease Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Sexually Transmitted Disease Therapeutics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Sexually Transmitted Disease Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Sexually Transmitted Disease Therapeutics Sales Market Share by Country/Region (2024)
Figure 8. Sexually Transmitted Disease Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Sexually Transmitted Disease Therapeutics Market Size Market Share by Type in 2024
Figure 10. Sexually Transmitted Disease Therapeutics in Hospitals
Figure 11. Global Sexually Transmitted Disease Therapeutics Market: Hospitals (2020-2025) & ($ millions)
Figure 12. Sexually Transmitted Disease Therapeutics in Diagnostic Laboratories
Figure 13. Global Sexually Transmitted Disease Therapeutics Market: Diagnostic Laboratories (2020-2025) & ($ millions)
Figure 14. Sexually Transmitted Disease Therapeutics in Research and Academic Laboratories
Figure 15. Global Sexually Transmitted Disease Therapeutics Market: Research and Academic Laboratories (2020-2025) & ($ millions)
Figure 16. Sexually Transmitted Disease Therapeutics in Others
Figure 17. Global Sexually Transmitted Disease Therapeutics Market: Others (2020-2025) & ($ millions)
Figure 18. Global Sexually Transmitted Disease Therapeutics Market Size Market Share by Application in 2024
Figure 19. Global Sexually Transmitted Disease Therapeutics Revenue Market Share by Player in 2024
Figure 20. Global Sexually Transmitted Disease Therapeutics Market Size Market Share by Region (2020-2025)
Figure 21. Americas Sexually Transmitted Disease Therapeutics Market Size 2020-2025 ($ millions)
Figure 22. APAC Sexually Transmitted Disease Therapeutics Market Size 2020-2025 ($ millions)
Figure 23. Europe Sexually Transmitted Disease Therapeutics Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Sexually Transmitted Disease Therapeutics Market Size 2020-2025 ($ millions)
Figure 25. Americas Sexually Transmitted Disease Therapeutics Value Market Share by Country in 2024
Figure 26. United States Sexually Transmitted Disease Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Sexually Transmitted Disease Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Sexually Transmitted Disease Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Sexually Transmitted Disease Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Sexually Transmitted Disease Therapeutics Market Size Market Share by Region in 2024
Figure 31. APAC Sexually Transmitted Disease Therapeutics Market Size Market Share by Type (2020-2025)
Figure 32. APAC Sexually Transmitted Disease Therapeutics Market Size Market Share by Application (2020-2025)
Figure 33. China Sexually Transmitted Disease Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Sexually Transmitted Disease Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Sexually Transmitted Disease Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Sexually Transmitted Disease Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 37. India Sexually Transmitted Disease Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Sexually Transmitted Disease Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Sexually Transmitted Disease Therapeutics Market Size Market Share by Country in 2024
Figure 40. Europe Sexually Transmitted Disease Therapeutics Market Size Market Share by Type (2020-2025)
Figure 41. Europe Sexually Transmitted Disease Therapeutics Market Size Market Share by Application (2020-2025)
Figure 42. Germany Sexually Transmitted Disease Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 43. France Sexually Transmitted Disease Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Sexually Transmitted Disease Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Sexually Transmitted Disease Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Sexually Transmitted Disease Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Sexually Transmitted Disease Therapeutics Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Sexually Transmitted Disease Therapeutics Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa Sexually Transmitted Disease Therapeutics Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Sexually Transmitted Disease Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Sexually Transmitted Disease Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Sexually Transmitted Disease Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey Sexually Transmitted Disease Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Sexually Transmitted Disease Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Sexually Transmitted Disease Therapeutics Market Size 2026-2031 ($ millions)
Figure 56. APAC Sexually Transmitted Disease Therapeutics Market Size 2026-2031 ($ millions)
Figure 57. Europe Sexually Transmitted Disease Therapeutics Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Sexually Transmitted Disease Therapeutics Market Size 2026-2031 ($ millions)
Figure 59. United States Sexually Transmitted Disease Therapeutics Market Size 2026-2031 ($ millions)
Figure 60. Canada Sexually Transmitted Disease Therapeutics Market Size 2026-2031 ($ millions)
Figure 61. Mexico Sexually Transmitted Disease Therapeutics Market Size 2026-2031 ($ millions)
Figure 62. Brazil Sexually Transmitted Disease Therapeutics Market Size 2026-2031 ($ millions)
Figure 63. China Sexually Transmitted Disease Therapeutics Market Size 2026-2031 ($ millions)
Figure 64. Japan Sexually Transmitted Disease Therapeutics Market Size 2026-2031 ($ millions)
Figure 65. Korea Sexually Transmitted Disease Therapeutics Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Sexually Transmitted Disease Therapeutics Market Size 2026-2031 ($ millions)
Figure 67. India Sexually Transmitted Disease Therapeutics Market Size 2026-2031 ($ millions)
Figure 68. Australia Sexually Transmitted Disease Therapeutics Market Size 2026-2031 ($ millions)
Figure 69. Germany Sexually Transmitted Disease Therapeutics Market Size 2026-2031 ($ millions)
Figure 70. France Sexually Transmitted Disease Therapeutics Market Size 2026-2031 ($ millions)
Figure 71. UK Sexually Transmitted Disease Therapeutics Market Size 2026-2031 ($ millions)
Figure 72. Italy Sexually Transmitted Disease Therapeutics Market Size 2026-2031 ($ millions)
Figure 73. Russia Sexually Transmitted Disease Therapeutics Market Size 2026-2031 ($ millions)
Figure 74. Egypt Sexually Transmitted Disease Therapeutics Market Size 2026-2031 ($ millions)
Figure 75. South Africa Sexually Transmitted Disease Therapeutics Market Size 2026-2031 ($ millions)
Figure 76. Israel Sexually Transmitted Disease Therapeutics Market Size 2026-2031 ($ millions)
Figure 77. Turkey Sexually Transmitted Disease Therapeutics Market Size 2026-2031 ($ millions)
Figure 78. Global Sexually Transmitted Disease Therapeutics Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global Sexually Transmitted Disease Therapeutics Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries Sexually Transmitted Disease Therapeutics Market Size 2026-2031 ($ millions)